Latest Rare diseases Stories
New organization named the EB Research Partnership NEW YORK, Oct.
"Food for Thought" to Promote Education, Fundraising for Rare Brain Disease RADNOR, Pa., Sept. 30, 2014 /PRNewswire-USNewswire/ -- Supporters from throughout the U.S.
CLEVELAND, Sept. 30, 2014 /PRNewswire/ -- Synapse Biomedical Inc.
MarketOptimizer.org adds “PharmaPoint: Neuropathic Pain - Global Drug Forecast and Market Analysis to 2022” to its store.
In his new role, Philip plans to use his position on the Board to advance MSA awareness, educate health professionals and collaborate with other charities to make government funding available
Employees and Families Raise Funds, Awareness at Annual Family Picnic WASHINGTON, Sept.
Beyond Batten Disease Foundation Delivers the Largest Investment in the History of Batten Research to Texas Children’s Hospital Houston, TX (PRWEB) September
- Data suggest support for potential label expansion of XIAFLEX for Dupuytren's contracture to include treatment of two affected joints concurrently; PDUFA date is October 20, 2014 - LYNBROOK,
Data Support CCH could be Used to Treat Two Affected Joints Concurrently; Positive Results Presented from Additional Studies Evaluating CCH Retreatment for Recurrent Contracture CHESTERBROOK,
ANNAPOLIS, Md., Sept.